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Uptake and degradation of virus-associated fluorescent sulfatide by skin 
fibroblasts 
A guarescent derivative ofcerebroside sulf;xte, pyrene-dodecanoyi sphingasyfgaract~sylsutfate (PIZ-CS) was incorporated into the envelope of vesf 
cular stomatitis virus (VEX). When the P12XX&mtaining virus was incubated for 24 h with skin fibroblasts, up to 40% of the sulfatide was located 
in the cells - a value at least 10 fold greater than that observed using sulfatide suspensions without virus. In a similar experiment, in which the 
24 h “pulse’ was followed by a 48 h ‘chase’, about E--20% of the virus-associated fluarescence was recovered in the skin Frbrablasts. Of the latter, 
about one-third was present as desulfated egradation products of P12-CS. The high uptake and degradation of the virusassociated sulfatide by 
intact skin fibroblasts suggested that on~d~psd viruses could be used for introducing other lipids into cells. This could be utiked for studying 
lipid catabolism and diagnosing lipid storage disarders in intact living cells. 
Cerebroside sulfa% Fhmreseent sulfatide; Pyrene suEtide; R~p~or~~t~ endocytosis; Sulfatide uptake; ~n~a~~~~~~ sulfatide metaboliiq 
Vesicular stoma&is virus 
1. INTRODUCTION 
Investigations of this laboratory, aimed at ad- 
ministering fatty acids and lipids into cultured cells and 
following their intracellular metabolism, utilized 
fluorescent fatty acids and lipids for this purpose 
[l-13]. 
Cerebroside sulfate ~su~fa~~~~ ac ~rn~~at~ in pa- 
tients v&h MLD, a lipidosis c~~~ter~d by a defi- 
ciency of the LysusomaL hydrolase arylsulfatase-A ]H]. 
Because of the presence of a “pseudodeficiency’ of this 
enzyme which provides false negative results in in vitro 
assays, Kihara et al. administered radioactively labeled 
sulfatides into skin fibroblasts and analyzed the 
degradation of the sulfatide in the intact cells [IS]. 
While cells derived from individuals with MLD 
pseudodeficiency degraded this compound at rates 
similar to those of normal calls, those from patients 
with MLIf did not do so 115j. We synthesized a ffuores- 
cent derivative of cerebraside stifate cent&&g 
covalence Linked Pf2-CS and in previous studies ad- 
ministered its d&per-Guns or complexes with albumin 
into normal or MLD ceiIs and followed its uptake and 
degradation [l 1,171. Either of these modes of disper- 
sion most probably resulted in initial incorporation of 
the sulfatide into the plasma membrane, from where 
they reached the lysosomes by as yet unclear and slow 
pathways. In this paper we describe the incorporation 
of pyrene-cerebroside sulfate into the envelope of VSV 
and application of receptor-mediated endocytic uptake 
of the virus for tr~~o~~ng the lipid into the lys~om~ 
comp~rn~~t of sidn ~brob~a~s where it ws degraded. 
2,1, Materials 
PY 24X was synthesized as described by March&u et al. [tgj, Fat- 
ty acid-free bovine serum albumin was obtained from Sigma. 
2.2. .Ksolutian of VSV 
Tan clay fertilized hen eggs were infected with VSV, incubated for 
4 days at 37°C and the ahantoic fluid was loaded on a discontinuous 
gradient of sucrose (2 ml of 22% layered over 0.5 of 30%) in 100 mM 
NaCl and 10 mM Tris buffer, pH 7.5. After centrifugjng 1 h at 
25 Ooo rpm in a SW-27 rotor. the 22% sucrose layer was c&ected, the 
virus again sedimented, dispersed in the above ‘&is-buffered Nat? 
solution, divided into several portions and stored at -7tYC. &awing 
the virus on fertifized eggs rather than CuXtwe~ celfs resulted in a 
lesser infectivity 119) and prevented Iysis of the skin fibroblasts. 
23. Dispersion of PlbCS 
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Abbreviations: PI-C!& pyrene-dodecanopl sphingosylgalactosyl-3- 
sulfate; VSV, vesicular stomatitis virus; RSA, bovine serum albumin; 
MLB, metachromatic leukodystropby; E/M, excimer to monomer 
ratio, i,e, the ratio of fluorescence err&&on al 475 and 378 nm, 
respe&vety 
(1) 30 nmol of PlZ-CS were dried in a glass tube, 150~1 saline 
(0,9% NaCl) were added and the tube was heated for 2 min at 90°C. 
After cooling, 150 $1 saline was added aud the tube was kept over- 
&ht at room temperature. (ii) 30 nmol PI%CS were dried in a glass 
tube and dissolved in 14 cl of dimethylsulfoxide, A solution of BSA 
CKWhhg 15, 30 or 60 nmol to provide O& 1.0, or 2.0 mol ratios 
of BSA to PlZ-CS, respectively).was dded. After 15 mh at 37”~ ttte 
~okune Wa5 brought to 300 & with saline and the tube was kept over- 
night at room temperature. 
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2.4. Introduction of PIZ-CS into VW membrane 
P12-CS (30 nmol in saline or complex with BSA) was incubated 
with a virus suspension (200 cg protein) in a final volume of 300 ,ul 
overnight at room temperature. The dispersion was transferred to 
ultra-clear centrifuge tubes of 250 ~1 (Beckman) and centrifuged in a 
Beckman Airfuge for 20 min at 100000 x g. The supernatant was col- 
lected and the sediment was dispersed in 100 ,ul of saline. An ahquot 
was diluted with 2 ml of saline and its fluorescence recorded using an 
excitation at 343 nm and emission at 378 nm (monomeric) or 475 nm 
(excimeric) in a Perkin-Elmer LS5 spectrofluorometer. Another ali- 
quot was added to 2 ml of chloroform-methanol 1: 1 (by vol.) and the 
fluorescence mission at 378 nm recorded. Control experiments using 
PlZ-CS dispersions or BSA-complexes, without virus, were processed 
by precisely the same procedure. 
2.5. Introduction of PIZ-CS into cells 
Skin fibroblasts were grown in 3 cm Petri dishes using minimal 
essential medium containing L-glutamine (200 mM), non-essential 
amino acids (1 mM) and supplemented with heat-denatured 10% 
fetal calf serum. The medium was removed and the supernatant or 
sediment (see above), were dispersed in 2 ml of serum-free medium. 
After 24 h at 37°C (‘pulse’) the medium was replaced with 2 ml 
medium containing 10% fetal calf serum and incubation continued 
for 48 hours more (‘chase’). The cells were then dislodged by mild 
trypsinization and the trypsin neutralized with serum-containing 
medium. The cells were sedimented, washed 3 times with saline, 
dispersed in 2 ml of saline and the fluorescence mission was deter- 
mined at 378 (monomeric) and 475 (excimeric) nm. The cells were 
resedimented and the lipids extracted for 5 min at 60°C with 2 ml of 
chloroform/methanol, 1: 1 (v/v). After centrifuging, the 
fluorescence of the lipids in the organic solvent was read at an excita- 
tion and emission of 343 and 378 nm. 
3. RESULTS AND DISCUSSION 
Table 1 shows the degree of association of P12-CS 
with the sedimented virus, incubated overnight with 
P12-CS in saline or complexed to albumin. For com- 
parison, data are also presented on P12-CS dispersions 
treated similarly but without virus. As shown in table 
1, the virus carried with it 80% of the PlZCS dispersed 
in the medium and about 50% of BSA-precomplexed 
sulfatide; the corresponding values in the sediments of 
Table 1 
Association of P12-CS with VSV 
Minus virus Plus virus 
% recovery E/M % recovery E/M 
P 12-CS dispersion 
Sediment 15 15 80 2.4 
Supernatant 10 6 6 0.6 
PlZ-CS:BSA 2: 1 
(mol ratio) 
Sediment 5 0.45 47 1.2 
Supernatant 93 0.8 30 0.5 
PlZCS (30 nmnol), dispersed in 0.9% NaCl, or precomplexed with 
BSA, was incubated overnight in a volume of 0.3 ml without or with 
virus and the tubes were centrifuged at 100000 x g. The respective 
supernatants were collected, the sediments dispersed and their 
fluorescence recorded in a spectrofluorometer. The lipids were 
extracted with chloroform-methanol mixtures and the fluorescence 
again recorded. For details see section 2. E/M, ‘excimer to monomer’ 
ratio [20,21] 
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controls devoid of virus, were only 15% and 5%, 
respectively. Incubation of the aqueous dispersion of 
the sulfatide with virus resulted in an overall recovery 
of about 90%, while the corresponding value for the 
dispersion without virus was only 25%, suggesting an 
adsorption of the dispersed PlZCS to the walls of the 
tubes which was not removed by the aqueous medium 
but was nearly completely desorbed by the virus. 
A comparison of the ‘excimer to monomer’ ratios 
(E/M, the ratio of the fluorescence mission at 475 to 
that at 378 nm), an indicator of the degree of aggrega- 
tion of the pyrene-sulfatide in intact cells [20,21], sug- 
gests that the virus which had been incubated with a 
PlZCS dispersion might have adsorbed rather than in- 
corporated the lipid into the viral envelope. Incubating 
a P12-CS-albumin complex having an excimer to 
monomer ratio of 0.45 with the virus, resulted in an in- 
creased E/M value of 1.2, suggesting aclose packing of 
the P12-CS molecules in the envelope of the virus, The 
47% recovery, in the virus, of the BSA-complexed 
P12-CS is equivalent to 14 nmol per 200 pg virus or 
70 nmol per mg, a value probably high enough to make 
plausible the excimer to monomer ratio of 1.2. 
When virus-associated P12-CS was incubated for 
24 h with skin fibroblasts in medium without serum 
(‘pulse’), about 40% of the P12-CS was recovered in 
the cells. Three experiments provided an average of 
5 nmol per dish or more than 50 nmol per mg protein. 
The corresponding value for cells incubated with a 
suspension or BSA-complex of P12-CS was about 10 
times smaller (data not shown). After washing the cells 
and replacing with fresh, serum-containing medium 
(chase) about 20% of the virus-associated fluorescence 
(i.e. 1.8 nmol) was recovered in the cells (table 2). The 
decrease during the 48 h ‘chase’ of the cell fluorescence 
from 5.75 to 1.8 nmol suggests lysosomal degradation 
Table 2 
Uptake of VSV-associated PlZCS by skin fibroblasts 
Exp. no. Virus-associated PlZ-CS Cell-associated fluorescence 
nmol % of nmol % of 
total virus-associated 
1 16.5 55 2.64 16 
2 13.2 44 1.45 11 
3 7.4 25 2.35 32 
4 13.75 46 1.50 11 
5 13.2 44 1.32 10 
6 9.6 32 1.34 14 
7 6.0 20 1.98 33 
Average 11.4 38 1.80 18 
PlZ-CS (30 nmol) was complexed with BSA at a mol ratio of 2: 1 and 
incubated in a volume of 0.3 ml with virus overnight; the virus was 
sedimented, redispersed and a portion was taken for determination of 
virus-associated fluorescence. The remainder was incubated with 
normal skin fibroblasts for 72 h (24 h ‘pulse’ and 48 h ‘chase’), the 
cells were collected and their associated fluorescence was recorded. 
For details see section 2 
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of the cell-associated PlZCS and elimination of about 
two-thirds of the fluorescent split products. 
When the chloroform-methanol extracts of the cells 
were filtered through DEAE-Sephadex, undegraded 
sulfatide was adsorbed and the effluent contained the 
metabolic degradation products of CS in the lipid ex- 
tract. In a typical experiment 12 nmol of virus- 
associated P12-CS was incubated with fibroblasts. 
After the 24 h ‘pulse’ and 48 h ‘chase’ periods, 
1.3 nmol of fluorescent lipids were present in the cell 
extract; of these, about one-third were eluted as non- 
sulfated degradation products (data not shown). 
The very high uptake, by skin fibroblasts of P12-CS, 
incorporated into the envelope of VSV-virus (about 
50 nmol per mg protein in 24 h) suggests a receptor 
mediated endocytosic uptake [22] and transport of the 
sulfatide, via endocytic vesicles [23-251 into the cell 
lysosomes [24], where they were efficiently degraded. 
Experiments are now planned to shorten the ‘pulse’ and 
‘chase’ periods and compare relative uptake and 
degradation by cells derived from normal individuals 
and patients with metachromatic leukodystrophy, 
which is characterized by absence of arylsulfatase A. 
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